Clinical Trials

Currently Enrolling

1. Janssen EMBRACE UTI Vaccine Trial-Vaccine for recurrent UTI’s. Must be 60 years or older and have a history of recurrent UTI’s in the past 2 years.

Recently Closed

1. Eyewitness HIV Switch Trial-For patients 50 years and older who are on Biktarvy and virologically suppressed. It is a switch from Biktarvy (which contains 3 ARV medications) to Dovato (which contains 2 ARV medications).
2. Acurx Pharmaceuticals, LLC-ACX-362F-201 Oral treatment for Clostridium difficile infection
3. CUSA-081-HEM-01-READY1 Reteplase for Dysfunctional Central Venous Access Devices
4. Sorrento Therapeutics, Inc DRP-COV-201US STI-2099 (COVI-DROPS) Intranasal COVID-19 treatment
5. DEFINE Study-Janssen Phase 4 HIV patients switching from an Integrase inhibitor with rapid weight gain.
6. SUMMIT-SMT19969/C004 Oral treatment for Clostridium difficile infection
7. ATLAS 2 M-GSK 207966 HIV-1 Intramuscular treatment
8. ATLAS 1-GSK 201585 HIV-1 transition from current INI-NNRTI to long-acting treatment.
9. TANGO GSK 204862 HIV-1 Devoto